Relationship between CIP2A expression, and prognosis and MDR-related proteins in patients with advanced gastric cancer.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Clinical and Experimental Pathology

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 26823836PMCID PMC4713622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

  2009cited by this paper
• CIP2A Is Associated with Human Breast Cancer Aggressivity

  2009cited by this paper
• Expression of Multidrug Resistance-Related Proteins p-Glycoproteinglutathione-s-Transferases, Topoisomerase-II and Lung Resistance Protein in Primary Gastric Cardiac Adenocarcinoma

  2008cited by this paper
• CIP2A Is Overexpressed in Gastric Cancer and Its Depletion Leads to Impaired Clonogenicity, Senescence, or Differentiation of Tumor Cells

  2008cited by this paper
• Mechanisms of MYC stabilization in human malignancies

  2008cited by this paper
• CIP2A inhibits PP2A in human malignancies.

  2007cited by this paper
• Fluoxetine and reversal of multidrug resistance.

  2006cited by this paper
• Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

  2006cited by this paper
• Incidence and mortality of gastric cancer in China.

  2006cited by this paper
• Protein Phosphatase 2A Regulatory Subunit B56α Associates with c-Myc and Negatively Regulates c-Myc Accumulation

  2006cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers.

  2005cited by this paper
• A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

  2004cited by this paper
• Helicobacter pylori and gastrointestinal tract adenocarcinomas

  2002cited by this paper
• Cloning and characterization of a novel 90 kDa ‘companion’ auto-antigen of p62 overexpressed in cancer

  2002cited by this paper
• Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc.

  1994cited by this paper
• Molecular biology and gastric carcinoma.

  1993cited by this paper
• Adenocarcinoma of the stomach: are we making progress?

  1993cited by this paper

• SOX chemotherapy is effective treatment for gastric cancer with liver metastases.

  2024cites this paper
• From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer

  2023cites this paper
• Integrative assessment of CIP2A overexpression and mutational effects in human malignancies identifies possible deleterious variants

  2021cites this paper
• BBOX1-AS1 Accelerates Gastric Cancer Proliferation by Sponging miR-3940-3p to Upregulate BIRC5 Expression

  2020cites this paper
• SOX Chemotherapy is Effective Treatment for Gastric Cancer with Liver Metastases: A Case Report

  2020cites this paper
• Role of microRNAs in drug resistance of gastric cancer cells

  2019cites this paper
• Knockdown of long non-coding RNA ANRIL inhibits tumorigenesis in human gastric cancer cells via microRNA-99a-mediated down-regulation of BMI1

  2018cites this paper
• Prognostic significance of CIP2A expression in solid tumors: A meta-analysis

  2018cites this paper
• Effects and mechanisms of miR-133 a on invasion and migration of gastric cancer cells MKN 28

  2017cites this paper
• Gastric Cancer: Biological Markers as Prognostic Factor

  2017cites this paper
• Expression and significance of CD28, CTLA-4, CD80 and CD86 in gastric cancer

  2017cites this paper
• GASTRIC CANCER: BIOLOGICAL MARKERS AS PROGNOSTIC FACTOR

  2017cites this paper
• Laparoscopic versus open total gastrectomy for advanced proximal gastric carcinoma: a matched pair analysis.

  2016cites this paper